@Avasbind and I had a lot of fun! Thankfully, there was Dr. Jean Kim (Card Onc) and her husband Dr. Kyle Miyazaki (oncologist) who joined the session to provide various insights! Thank you to those who came to our session! Amazing conference as always, @AHAScience
Huge congrats to Hanni, a PhD student on our team, for delivering a fantastic presentation sharing pilot data from our exercise prehabilitation study for bone marrow transplant recipients (CAREFit-BMT 💪🫀). Well done! @UWSoN
Dr. Alexi Vasbinder @Avasbind presented "Incidence and Risk Factors of Cardiovascular Events after GvHD among allogeneic SCT recipients." Higher MACE rates seen acute and chronic GvHD.
#ACC25#CardioOnc
3/10
What an honor to be a guest on the #AllThingsCardioOncology podcast hosted by @ICOSociety to talk about the cardiovascular management in stem cell transplant🎙️🫀
You can check it out on Spotify 💚:
https://t.co/0iOqH5dEJB
"🚨💡 New podcast episode! Join @Avasbind as she shares her work with @salimhayek on Cardiovascular Events After Hematopoietic Stem Cell Transplant 🫀, including the CARE-BMT Risk Score. 🧬🎙🔗 https://t.co/HEUIORicgw #CardioOnc#CardioTwitter"
What a great team to work with! This review highlights the importance of considering non-traditional risk factors in #CardioOncology research and practice such as SDOH, environmental factors, multi-omics, wearables, and more!
Out now in JCEM, multicenter study from the International Study of Inflammation in #COVID19, @CardiacLab, @umich exploring the mediating role of #inflammation between obesity and outcomes across the Covid-19 pandemic in 4,644 hospitalized patients. 1/4🧵
https://t.co/irtSvmeXjU